| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 |
| NetGPI | no | yes: 0, no: 11 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005634 | nucleus | 5 | 12 |
| GO:0043226 | organelle | 2 | 12 |
| GO:0043227 | membrane-bounded organelle | 3 | 12 |
| GO:0043229 | intracellular organelle | 3 | 12 |
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 12 |
| GO:0110165 | cellular anatomical entity | 1 | 12 |
| GO:0030896 | checkpoint clamp complex | 3 | 1 |
| GO:0032991 | protein-containing complex | 1 | 1 |
| GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: E9AUI3
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000075 | cell cycle checkpoint signaling | 4 | 12 |
| GO:0000077 | DNA damage checkpoint signaling | 5 | 12 |
| GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
| GO:0006259 | DNA metabolic process | 4 | 12 |
| GO:0006281 | DNA repair | 5 | 12 |
| GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
| GO:0006950 | response to stress | 2 | 12 |
| GO:0006974 | DNA damage response | 4 | 12 |
| GO:0007165 | signal transduction | 2 | 12 |
| GO:0008152 | metabolic process | 1 | 12 |
| GO:0009987 | cellular process | 1 | 12 |
| GO:0010564 | regulation of cell cycle process | 5 | 12 |
| GO:0010948 | negative regulation of cell cycle process | 6 | 12 |
| GO:0031570 | DNA integrity checkpoint signaling | 5 | 12 |
| GO:0033554 | cellular response to stress | 3 | 12 |
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
| GO:0035556 | intracellular signal transduction | 3 | 12 |
| GO:0042770 | signal transduction in response to DNA damage | 4 | 12 |
| GO:0043170 | macromolecule metabolic process | 3 | 12 |
| GO:0044237 | cellular metabolic process | 2 | 12 |
| GO:0044238 | primary metabolic process | 2 | 12 |
| GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 12 |
| GO:0045786 | negative regulation of cell cycle | 5 | 12 |
| GO:0046483 | heterocycle metabolic process | 3 | 12 |
| GO:0048519 | negative regulation of biological process | 3 | 12 |
| GO:0048523 | negative regulation of cellular process | 4 | 12 |
| GO:0050789 | regulation of biological process | 2 | 12 |
| GO:0050794 | regulation of cellular process | 3 | 12 |
| GO:0050896 | response to stimulus | 1 | 12 |
| GO:0051716 | cellular response to stimulus | 2 | 12 |
| GO:0051726 | regulation of cell cycle | 4 | 12 |
| GO:0065007 | biological regulation | 1 | 12 |
| GO:0071704 | organic substance metabolic process | 2 | 12 |
| GO:0090304 | nucleic acid metabolic process | 4 | 12 |
| GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
| GO:1901987 | regulation of cell cycle phase transition | 6 | 12 |
| GO:1901988 | negative regulation of cell cycle phase transition | 7 | 12 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 1 |
| GO:0004518 | nuclease activity | 4 | 1 |
| GO:0004527 | exonuclease activity | 5 | 1 |
| GO:0004529 | DNA exonuclease activity | 5 | 1 |
| GO:0004536 | DNA nuclease activity | 4 | 1 |
| GO:0008853 | obsolete exodeoxyribonuclease III activity | 7 | 1 |
| GO:0016787 | hydrolase activity | 2 | 1 |
| GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
| GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 1 |
| GO:0016895 | DNA exonuclease activity, producing 5'-phosphomonoesters | 6 | 1 |
| GO:0140097 | catalytic activity, acting on DNA | 3 | 1 |
| GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 284 | 288 | PF00656 | 0.707 |
| CLV_C14_Caspase3-7 | 75 | 79 | PF00656 | 0.380 |
| CLV_MEL_PAP_1 | 157 | 163 | PF00089 | 0.452 |
| CLV_PCSK_SKI1_1 | 56 | 60 | PF00082 | 0.411 |
| CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.321 |
| CLV_PCSK_SKI1_1 | 93 | 97 | PF00082 | 0.372 |
| DEG_APCC_DBOX_1 | 152 | 160 | PF00400 | 0.526 |
| DOC_CYCLIN_RxL_1 | 53 | 61 | PF00134 | 0.461 |
| DOC_MAPK_gen_1 | 150 | 159 | PF00069 | 0.431 |
| DOC_MAPK_HePTP_8 | 192 | 204 | PF00069 | 0.486 |
| DOC_MAPK_MEF2A_6 | 153 | 161 | PF00069 | 0.442 |
| DOC_MAPK_MEF2A_6 | 195 | 204 | PF00069 | 0.493 |
| DOC_MAPK_MEF2A_6 | 345 | 353 | PF00069 | 0.479 |
| DOC_MAPK_MEF2A_6 | 6 | 14 | PF00069 | 0.384 |
| DOC_PP2B_LxvP_1 | 71 | 74 | PF13499 | 0.471 |
| DOC_USP7_MATH_1 | 307 | 311 | PF00917 | 0.675 |
| DOC_USP7_MATH_1 | 359 | 363 | PF00917 | 0.552 |
| DOC_USP7_MATH_1 | 88 | 92 | PF00917 | 0.559 |
| DOC_WW_Pin1_4 | 107 | 112 | PF00397 | 0.537 |
| DOC_WW_Pin1_4 | 6 | 11 | PF00397 | 0.497 |
| LIG_14-3-3_CanoR_1 | 141 | 147 | PF00244 | 0.536 |
| LIG_14-3-3_CanoR_1 | 15 | 21 | PF00244 | 0.463 |
| LIG_14-3-3_CanoR_1 | 160 | 167 | PF00244 | 0.301 |
| LIG_14-3-3_CanoR_1 | 237 | 245 | PF00244 | 0.461 |
| LIG_14-3-3_CanoR_1 | 289 | 298 | PF00244 | 0.584 |
| LIG_14-3-3_CanoR_1 | 327 | 331 | PF00244 | 0.467 |
| LIG_14-3-3_CanoR_1 | 336 | 341 | PF00244 | 0.266 |
| LIG_Actin_WH2_2 | 145 | 162 | PF00022 | 0.535 |
| LIG_APCC_ABBA_1 | 37 | 42 | PF00400 | 0.391 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.356 |
| LIG_BRCT_BRCA1_1 | 120 | 124 | PF00533 | 0.444 |
| LIG_deltaCOP1_diTrp_1 | 25 | 32 | PF00928 | 0.352 |
| LIG_FHA_1 | 147 | 153 | PF00498 | 0.409 |
| LIG_FHA_1 | 17 | 23 | PF00498 | 0.416 |
| LIG_FHA_1 | 238 | 244 | PF00498 | 0.426 |
| LIG_FHA_1 | 327 | 333 | PF00498 | 0.434 |
| LIG_FHA_1 | 352 | 358 | PF00498 | 0.377 |
| LIG_FHA_1 | 49 | 55 | PF00498 | 0.380 |
| LIG_FHA_1 | 90 | 96 | PF00498 | 0.463 |
| LIG_FHA_2 | 108 | 114 | PF00498 | 0.479 |
| LIG_FHA_2 | 129 | 135 | PF00498 | 0.680 |
| LIG_FHA_2 | 174 | 180 | PF00498 | 0.432 |
| LIG_FHA_2 | 341 | 347 | PF00498 | 0.493 |
| LIG_FHA_2 | 73 | 79 | PF00498 | 0.408 |
| LIG_LIR_Gen_1 | 2 | 12 | PF02991 | 0.380 |
| LIG_LIR_Gen_1 | 25 | 32 | PF02991 | 0.368 |
| LIG_LIR_Gen_1 | 293 | 302 | PF02991 | 0.607 |
| LIG_LIR_Gen_1 | 361 | 367 | PF02991 | 0.513 |
| LIG_LIR_Gen_1 | 61 | 70 | PF02991 | 0.498 |
| LIG_LIR_Nem_3 | 2 | 7 | PF02991 | 0.368 |
| LIG_LIR_Nem_3 | 25 | 30 | PF02991 | 0.381 |
| LIG_LIR_Nem_3 | 320 | 325 | PF02991 | 0.490 |
| LIG_LIR_Nem_3 | 361 | 367 | PF02991 | 0.513 |
| LIG_LIR_Nem_3 | 61 | 65 | PF02991 | 0.448 |
| LIG_NRBOX | 142 | 148 | PF00104 | 0.529 |
| LIG_PDZ_Class_3 | 362 | 367 | PF00595 | 0.585 |
| LIG_PTB_Apo_2 | 289 | 296 | PF02174 | 0.624 |
| LIG_PTB_Phospho_1 | 289 | 295 | PF10480 | 0.625 |
| LIG_SH2_CRK | 4 | 8 | PF00017 | 0.381 |
| LIG_SH2_NCK_1 | 62 | 66 | PF00017 | 0.509 |
| LIG_SH2_STAP1 | 239 | 243 | PF00017 | 0.523 |
| LIG_SH2_STAT5 | 239 | 242 | PF00017 | 0.539 |
| LIG_SH2_STAT5 | 295 | 298 | PF00017 | 0.624 |
| LIG_SH2_STAT5 | 4 | 7 | PF00017 | 0.363 |
| LIG_SH3_3 | 353 | 359 | PF00018 | 0.394 |
| LIG_SUMO_SIM_anti_2 | 354 | 359 | PF11976 | 0.442 |
| LIG_SUMO_SIM_par_1 | 105 | 110 | PF11976 | 0.369 |
| LIG_SUMO_SIM_par_1 | 18 | 23 | PF11976 | 0.407 |
| LIG_SUMO_SIM_par_1 | 221 | 229 | PF11976 | 0.560 |
| MOD_CDK_SPxxK_3 | 107 | 114 | PF00069 | 0.550 |
| MOD_CK1_1 | 126 | 132 | PF00069 | 0.678 |
| MOD_CK1_1 | 233 | 239 | PF00069 | 0.473 |
| MOD_CK1_1 | 259 | 265 | PF00069 | 0.750 |
| MOD_CK1_1 | 86 | 92 | PF00069 | 0.539 |
| MOD_GlcNHglycan | 120 | 123 | PF01048 | 0.606 |
| MOD_GlcNHglycan | 125 | 128 | PF01048 | 0.609 |
| MOD_GlcNHglycan | 258 | 261 | PF01048 | 0.654 |
| MOD_GlcNHglycan | 302 | 305 | PF01048 | 0.632 |
| MOD_GlcNHglycan | 309 | 312 | PF01048 | 0.577 |
| MOD_GSK3_1 | 126 | 133 | PF00069 | 0.614 |
| MOD_GSK3_1 | 142 | 149 | PF00069 | 0.439 |
| MOD_GSK3_1 | 16 | 23 | PF00069 | 0.412 |
| MOD_GSK3_1 | 226 | 233 | PF00069 | 0.516 |
| MOD_GSK3_1 | 255 | 262 | PF00069 | 0.739 |
| MOD_GSK3_1 | 26 | 33 | PF00069 | 0.306 |
| MOD_GSK3_1 | 336 | 343 | PF00069 | 0.404 |
| MOD_GSK3_1 | 46 | 53 | PF00069 | 0.434 |
| MOD_N-GLC_1 | 46 | 51 | PF02516 | 0.522 |
| MOD_NEK2_1 | 142 | 147 | PF00069 | 0.431 |
| MOD_NEK2_1 | 273 | 278 | PF00069 | 0.728 |
| MOD_NEK2_1 | 300 | 305 | PF00069 | 0.591 |
| MOD_NEK2_1 | 32 | 37 | PF00069 | 0.425 |
| MOD_NEK2_1 | 48 | 53 | PF00069 | 0.512 |
| MOD_NEK2_2 | 281 | 286 | PF00069 | 0.465 |
| MOD_NEK2_2 | 317 | 322 | PF00069 | 0.628 |
| MOD_NEK2_2 | 359 | 364 | PF00069 | 0.544 |
| MOD_PIKK_1 | 340 | 346 | PF00454 | 0.522 |
| MOD_PK_1 | 336 | 342 | PF00069 | 0.404 |
| MOD_PKA_2 | 159 | 165 | PF00069 | 0.523 |
| MOD_PKA_2 | 273 | 279 | PF00069 | 0.696 |
| MOD_PKA_2 | 288 | 294 | PF00069 | 0.375 |
| MOD_PKA_2 | 326 | 332 | PF00069 | 0.442 |
| MOD_Plk_1 | 190 | 196 | PF00069 | 0.470 |
| MOD_Plk_4 | 142 | 148 | PF00069 | 0.491 |
| MOD_Plk_4 | 26 | 32 | PF00069 | 0.422 |
| MOD_Plk_4 | 317 | 323 | PF00069 | 0.595 |
| MOD_Plk_4 | 336 | 342 | PF00069 | 0.397 |
| MOD_Plk_4 | 351 | 357 | PF00069 | 0.329 |
| MOD_Plk_4 | 359 | 365 | PF00069 | 0.493 |
| MOD_Plk_4 | 72 | 78 | PF00069 | 0.486 |
| MOD_ProDKin_1 | 107 | 113 | PF00069 | 0.553 |
| MOD_ProDKin_1 | 6 | 12 | PF00069 | 0.495 |
| MOD_SUMO_rev_2 | 101 | 106 | PF00179 | 0.559 |
| MOD_SUMO_rev_2 | 191 | 200 | PF00179 | 0.493 |
| MOD_SUMO_rev_2 | 346 | 352 | PF00179 | 0.585 |
| TRG_DiLeu_BaEn_2 | 347 | 353 | PF01217 | 0.471 |
| TRG_ENDOCYTIC_2 | 211 | 214 | PF00928 | 0.502 |
| TRG_ENDOCYTIC_2 | 295 | 298 | PF00928 | 0.617 |
| TRG_ENDOCYTIC_2 | 364 | 367 | PF00928 | 0.531 |
| TRG_ENDOCYTIC_2 | 4 | 7 | PF00928 | 0.363 |
| TRG_ENDOCYTIC_2 | 62 | 65 | PF00928 | 0.500 |
| TRG_Pf-PMV_PEXEL_1 | 104 | 108 | PF00026 | 0.369 |
| TRG_Pf-PMV_PEXEL_1 | 178 | 183 | PF00026 | 0.513 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1HUB9 | Leptomonas seymouri | 69% | 100% |
| A0A0S4J1V0 | Bodo saltans | 31% | 100% |
| A0A1X0NWX4 | Trypanosomatidae | 44% | 100% |
| A0A3S7WVU5 | Leishmania donovani | 95% | 100% |
| A0A422NCM6 | Trypanosoma rangeli | 41% | 100% |
| A4HYN1 | Leishmania infantum | 96% | 100% |
| C9ZI59 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 100% |
| E9AI98 | Leishmania braziliensis | 88% | 97% |
| Q4QD01 | Leishmania major | 93% | 99% |
| V5BVI1 | Trypanosoma cruzi | 42% | 100% |